Low oxygen tension positively influences cardiomyocyte progenitor cell function

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 12, 2011, Pages 2723-2734

  van Oorschot, Angelique A M ^a   Smits, Anke M ^a   Pardali, Evangelia ^a   Doevendans, Pieter A ^b,c   Goumans, Marie José ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Cardiomyocyte progenitor cells; Hypoxia, proliferation; Migration; Thrombospondin 2

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; OXYGEN; THROMBOSPONDIN 1;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CELL; HUMAN; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETUS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASES; MYOCYTES, CARDIAC; OXYGEN; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; THROMBOSPONDIN 1; UMBILICAL VEINS;

EID: 82455184930     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01270.x     Document Type: Article

References (63)

1. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA. 2007; 104: 14068-73.
2. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95: 911-21.
3. Goumans MJ, de Boer TP, Smits AM, et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytesin vitro. Stem Cell Res. 2007; 1: 138-49.
4. van Oorschot AA, Smits AM, Goumans MJ. Stem cells: the building blocks to repair the injured heart. Panminerva Med. 2010; 52: 97-110.
5. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009; 324: 98-102.
6. Kajstura J, Urbanek K, Perl S, et al. Cardiomyogenesis in the adult human heart. Circ Res. 2010; 107: 305-15.
7. Kook SH, Son YO, Lee KY, et al. Hypoxia affects positively the proliferation of bovine satellite cells and their myogenic differentiation through up-regulation of MyoD. Cell Biol Int. 2008; 32: 871-8.
8. Nakanishi C, Yamagishi M, Yamahara K, et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun. 2008; 374: 11-6.
9. Oberringer M, Meins C, Bubel M, et al. In vitrowounding: effects of hypoxia and transforming growth factor beta1 on proliferation, migration and myofibroblastic differentiation in an endothelial cell-fibroblast co-culture model. J Mol Histol. 2008; 39: 37-47.
10. Grayson WL, Zhao F, Bunnell B, et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun. 2007; 358: 948-53.
11. Lennon DP, Edmison JM, Caplan AI. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects onin vitroandin vivoosteochondrogenesis. J Cell Physiol. 2001; 187: 345-55.
12. Csete M. Oxygen in the cultivation of stem cells. Ann NY Acad Sci. 2005; 1049: 1-8.
13. Csete M, Walikonis J, Slawny N, et al. Oxygen-mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture. J Cell Physiol. 2001; 189: 189-96.
14. Studer L, Csete M, Lee SH, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci. 2000; 20: 7377-83.
15. Horie N, So K, Moriya T, et al. Effects of oxygen concentration on the proliferation and differentiation of mouse neural stem cellsin vitro. Cell Mol Neurobiol. 2008; 28: 833-45.
16. Ju SY, Cho KA, Cho SJ, et al. Effect of hypoxic treatment on bone marrow cells that are able to migrate to the injured liver. Cell Biol Int. 2009; 33: 31-5.
17. Zhang L. Prenatal hypoxia and cardiac programming. J Soc Gynecol Investig. 2005; 12: 2-13.
18. Rabelink TJ, de Boer HC, de Koning EJ, et al. Endothelial progenitor cells: more than an inflammatory response Arterioscler Thromb Vasc Biol. 2004; 24: 834-8.
19. Juhasz B, Der P, Szodoray P, et al. Adrenocorticotrope hormone fragment (4-10) attenuates the ischemia/reperfusion-induced cardiac injury in isolated rat hearts. Antioxid Redox Signal. 2007; 9: 1851-61.
20. Liesmaa I, Leskinen HK, Kokkonen JO, et al. Hypoxia-induced expression of bradykinin type-2 receptors in endothelial cells triggers NO production, cell migration, and angiogenesis. J Cell Physiol. 2009; 221: 359-66.
21. Lin Q, Lee YJ, Yun Z. Differentiation arrest by hypoxia. J Biol Chem. 2006; 281: 30678-83.
22. Smits AM, van Vliet P, Metz CH, et al. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: anin vitromodel for studying human cardiac physiology and pathophysiology. Nat Protoc. 2009; 4: 232-43.
23. van Vliet P, Roccio M, Smits AM, et al. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J. 2008; 16: 163-9.
24. Smits AM, van Laake LW, den Ouden K, et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res. 2009; 83: 527-35.
25. Liu Z, Kobayashi K, van Dinther M, et al. VEGF and inhibitors of TGF{beta} type-I receptor kinase synergistically promote blood-vessel formation by inducing {alpha}5-integrin expression. J Cell Sci. 2009; 122: 3294-302.
26. Pasterkamp G, Schoneveld AH, Hijnen DJ, et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis. 2000; 150: 245-53.
27. Blankesteijn WM, Creemers E, Lutgens E, et al. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand. 2001; 173: 75-82.
28. Schroen B, Heymans S, Sharma U, et al. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res. 2004; 95: 515-22.
29. Rousseau S, Houle F, Kotanides H, et al. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem. 2000; 275: 10661-72.
30. Fischer S, Clauss M, Wiesnet M, et al. Hypoxia induces permeability in brain microvessel endothelial cellsviaVEGF and NO. Am J Physiol. 1999; 276: C812-20.
31. Namiki A, Brogi E, Kearney M, et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem. 1995; 270: 31189-95.
32. Lee EY, Xia Y, Kim WS, et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen. 2009; 17: 540-7.
33. Jayachandran A, Konigshoff M, Yu H, et al. SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis. Thorax. 2009; 64: 1053-61.
34. Lundgren K, Nordenskjold B, Landberg G. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer. 2009; 101: 1769-81.
35. VanSaun MN, Matrisian LM. Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res C Embryo Today. 2006; 78: 69-79.
36. Bellayr I, Mu X, Li Y. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem. 2009; 1: 1095-111.
37. Creemers EE, Cleutjens JP, Smits JF, et al. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure Circ Res. 2001; 89: 201-10.
38. Vanhoutte D, Schellings M, Pinto Y, et al. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res. 2006; 69: 604-13.
39. Mannello F, Tonti GA, Bagnara GP, et al. Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. Stem Cells. 2006; 24: 475-81.
40. Steingen C, Brenig F, Baumgartner L, et al. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol. 2008; 44: 1072-84.
41. Xu X, Xu Z, Xu Y, et al. Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis. 2005; 16: 245-55.
42. Mias C, Lairez O, Trouche E, et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells. 2009; 27: 2734-43.
43. Perez-Ilzarbe M, Agbulut O, Pelacho B, et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail. 2008; 10: 1065-72.
44. Maclauchlan S, Skokos EA, Agah A, et al. Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF. J Histochem Cytochem. 2009; 57: 301-13.
45. Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure overloaded heart. Cardiovasc Res. 2011; 89: 265-72.
46. Kyriakides TR, Wulsin D, Skokos EA, et al. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol. 2009; 28: 65-73.
47. Goda N, Dozier SJ, Johnson RS. HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal. 2003; 5: 467-73.
48. Marx J. Cell biology. How cells endure low oxygen. Science. 2004; 303: 1454-6.
49. Reykdal S, Abboud C, Liesveld J. Effect of nitric oxide production and oxygen tension on progenitor preservation inex vivoculture. Exp Hematol. 1999; 27: 441-50.
50. Potier E, Ferreira E, Andriamanalijaona R, et al. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone. 2007; 40: 1078-87.
51. Gobble RM, Groesch KA, Chang M, et al. Differential regulation of human PlGF gene expression in trophoblast and nontrophoblast cells by oxygen tension. Placenta. 2009; 30: 869-75.
52. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001; 7: 575-83.
53. Luttun A, Brusselmans K, Fukao H, et al. Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun. 2002; 295: 428-34.
54. Thirunavukkarasu M, Penumathsa SV, Koneru S, et al. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med. 2007; 43: 720-9.
55. Winter EM, van Oorschot AA, Hogers B, et al. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Circ Heart Fail. 2009; 2: 643-53.
56. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res. 2004; 53: 585-95.
57. Galindo M, Santiago B, Alcami J, et al. Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts. Clin Exp Immunol. 2001; 123: 36-41.
58. Boyle JJ. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol. 2005; 3: 63-8.
59. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA. 1987; 84: 5788-92.
60. Fava RA, Olsen NJ, Postlethwaite AE, et al. Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med. 1991; 173: 1121-32.
61. Frangogiannis NG, Ren G, Dewald O, et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation. 2005; 111: 2935-42.
62. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008; 214: 199-210.
63. Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006; 20: 661-9.